PlainRecalls
FDA Drug Moderate Class II Ongoing

Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.

Reported: September 24, 2025 Initiated: September 4, 2025 #D-0657-2025

Product Description

Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.

Reason for Recall

Failed Impurity/Degradation Specifications

Details

Units Affected
4440 bottles
Distribution
U.S. Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.. Recalled by Zydus Pharmaceuticals (USA) Inc. Units affected: 4440 bottles.
Why was this product recalled?
Failed Impurity/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on September 24, 2025. Severity: Moderate. Recall number: D-0657-2025.